Results Snapshot
Quarterly Analysis Highlights - QoQ
Net Sales
QoQ Growth in quarter ended Jun 2025 is -1.60% vs 0.41% in Mar 2025
Consolidate Net Profit
QoQ Growth in quarter ended Jun 2025 is 3.33% vs 125.00% in Mar 2025
Operating Profit (PBDIT) excl Other Income
QoQ Growth in quarter ended Jun 2025 is 0.58% vs 141.55% in Mar 2025
Interest
QoQ Growth in quarter ended Jun 2025 is -11.76% vs -86.72% in Mar 2025
Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Jun 2025 has improved from Mar 2025
Compare Quarterly Results Of Kangmei Pharmaceutical Co., Ltd. With
Quarterly - Net Sales
QoQ Growth in quarter ended Jun 2025 is -1.60% vs 0.41% in Mar 2025
YoY Growth in quarter ended Jun 2025 is 0.39% vs 4.79% in Jun 2024
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Jun 2025 is 3.33% vs 125.00% in Mar 2025
YoY Growth in quarter ended Jun 2025 is -2.11% vs 112.62% in Jun 2024
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Jun 2025 is 0.58% vs 141.55% in Mar 2025
YoY Growth in quarter ended Jun 2025 is 17.62% vs 429.46% in Jun 2024
Quarterly - Interest
QoQ Growth in quarter ended Jun 2025 is -11.76% vs -86.72% in Mar 2025
YoY Growth in quarter ended Jun 2025 is -51.61% vs -6.06% in Jun 2024
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Jun 2025 has improved from Mar 2025
YoY Growth in quarter ended Jun 2025 has improved from Jun 2024






